Profile
Sector:
HealthcareIndustry:
Medical DistributionCountry:
United StatesIPO:
17 March 1980Website:
http://www.owens-minor.comNext earnings report:
04 November 2024Last dividends:
14 December 2021Next dividends:
N/APrice
regular market | 2 min agoAnalysts recommendations
Institutional Ownership
OMI Latest News
Owens & Minor, Inc. (NYSE:OMI ) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Jackie Marcus - Investor Relations Edward Pesicka - President and Chief Executive Officer Jonathan Leon - Executive Vice President and Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Michael Cherny - Leerink Partners Allen Lutz - Bank of America John Stansel - JPMorgan Stephanie Davis - Barclays Eric Coldwell - Baird Daniel Grosslight - Citi Operator Good day, everyone, and thank you for standing by. Welcome to the Owens & Minor Third Quarter 2024 Earnings Conference Call.
Owens & Minor (OMI) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.44 per share a year ago.
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the third quarter, representing year-over-year growth of 5% GAAP Net loss of $(13) million or $(0.17) per share, and adjusted earnings per share of $0.42 in the third quarter Adjusted EBITDA of $142 million in the third quarter, representing year-over-year growth of 5% $198 million in total de.
LONDON, UK / ACCESSWIRE / November 1, 2024 / Orosur Mining Inc. ("Orosur" or "the Company") (TSXV:OMI)(AIM:OMI) announces the granting of an aggregate of 4,000,000 stock options over the Company's common shares ("Options") and an aggregate of 4,723,332 Restricted Stock Units ("RSUs") to directors, officers, employees and consultants, upon recommendation of the Company's Remuneration Committee as approved by shareholders at the Annual and Special Meeting held on December 19, 2023, full details of which are set out in the Company's 2023 Management Information Circular available on its website. Award of Options and RSUs In line with the Company's Equity Incentive Plan, officers, employees and consultants of the Company were granted a total of 1,750,000 Options and 1,680,000 RSUs and in addition, 2,250,000 Options and 1,350,000 RSUs were also granted to Directors, the first such awards made in more than two years.
Results for First Quarter ended August 31, 2024 LONDON, UK / ACCESSWIRE / October 30, 2024 / Orosur Mining Inc. ("Orosur" or "the Company") (TSXV:OMI)(AIM:OMI) the minerals developer and explorer with operations in Colombia, Argentina and Nigeria, announces its unaudited results for the quarter ended August 31, 2024. All dollar figures are stated in US$ unless otherwise noted.
LONDON, UNITED KINGDOM / ACCESSWIRE / October 18, 2024 / Orosur Mining Inc (TSXV:OMI)(AIM:OMI), the mineral explorer and developer with current operations in Columbia, Argentina and Nigeria, announces that Louis Castro, Chairman and Brad George, Chief Executive Officer, will be holding an Investor Webinar presentation followed by Q&A session via the Investor Meet Company platform on 22nd October at 5pm (UK local time). The presentation is open to all existing and potential shareholders.
Orosur Mining Inc - Colombia update Approval received from TSX.V for Anzá transaction Progressing with process of completion LONDON, UK / ACCESSWIRE / October 17, 2024 / Orosur Mining Inc. ("Orosur" or the "Company") (TSXV:OMI)(AIM:OMI) is pleased to announce that further to its news release of September 10th, 2024, the TSX.V has now granted approval of the transaction that would see Orosur returning to 100% ownership of the Anzá gold project in Colombia, subject to terms and deferred consideration as outlined in the Sept 10th announcement. The Company is now actively progressing toward technical completion of the Anzá transaction, with a view to commencement of field activities at Anzá as soon as possible.
LONDON, UK / ACCESSWIRE / October 4, 2024 / Orosur Mining Inc. ("Orosur" or the "Company") (TSXV:OMI)(AIM:OMI) is pleased to announce that further to the Company's announcement made on 30th September 2024, 30,035,971 new common shares of no par value in the Company (the "New Common Shares") have been admitted to trading on AIM today (the "Admission"), at a placing price of £0.0278 (CAD$0.05). Following the issue of the New Common Shares, which will rank pari passu with the existing common shares of the Company, the total number of common shares issued and outstanding with voting rights in the Company will be 235,620,423.
LONDON, UNITED KINGDOM / ACCESSWIRE / October 1, 2024 / Orosur Mining Inc. ("Orosur" or "the Company") (TSXV:OMI)(AIM:OMI) announces its audited results for the fiscal year ended May 31, 2024. All dollar figures are stated in thousands of US$ unless otherwise noted.
Negotiations on Share Purchase Agreement ("SPA") and ancillary documents successfully concluded SPA has been signed, subject to customary closing conditions and approval of the TSXV Company will reassume 100% ownership of its flagship Anza Gold Project in Colombia with no upfront payments Orosur will become operator of the Anza Gold Project LONDON, UNITED KINGDOM / ACCESSWIRE / September 10, 2024 / Orosur Mining Inc. ("Orosur" or the "Company") (TSXV:OMI)(AIM:OMI) is pleased to announce that further to its news release of March 25, 2024, negotiations of the terms of a definitive binding SPA and ancillary documentation have been successfully completed. The SPA has now been duly executed and, on the closing of the transaction, the Company will have 100% ownership of the Company's flagship Anzá Gold Project ("Anzá Project") in Colombia.
What type of business is Owens & Minor?
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
What sector is Owens & Minor in?
Owens & Minor is in the Healthcare sector
What industry is Owens & Minor in?
Owens & Minor is in the Medical Distribution industry
What country is Owens & Minor from?
Owens & Minor is headquartered in United States
When did Owens & Minor go public?
Owens & Minor initial public offering (IPO) was on 17 March 1980
What is Owens & Minor website?
https://www.owens-minor.com
Is Owens & Minor in the S&P 500?
No, Owens & Minor is not included in the S&P 500 index
Is Owens & Minor in the NASDAQ 100?
No, Owens & Minor is not included in the NASDAQ 100 index
Is Owens & Minor in the Dow Jones?
No, Owens & Minor is not included in the Dow Jones index
When was Owens & Minor the previous earnings report?
No data
When does Owens & Minor earnings report?
The next expected earnings date for Owens & Minor is 04 November 2024